These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
317 related articles for article (PubMed ID: 15123735)
1. Degradative organelles containing mislocalized alpha-and beta-synuclein proliferate in presenilin-1 null neurons. Wilson CA; Murphy DD; Giasson BI; Zhang B; Trojanowski JQ; Lee VM J Cell Biol; 2004 May; 165(3):335-46. PubMed ID: 15123735 [TBL] [Abstract][Full Text] [Related]
2. Presenilin 1 mediates the turnover of telencephalin in hippocampal neurons via an autophagic degradative pathway. Esselens C; Oorschot V; Baert V; Raemaekers T; Spittaels K; Serneels L; Zheng H; Saftig P; De Strooper B; Klumperman J; Annaert W J Cell Biol; 2004 Sep; 166(7):1041-54. PubMed ID: 15452145 [TBL] [Abstract][Full Text] [Related]
3. Impaired degradation of mutant alpha-synuclein by chaperone-mediated autophagy. Cuervo AM; Stefanis L; Fredenburg R; Lansbury PT; Sulzer D Science; 2004 Aug; 305(5688):1292-5. PubMed ID: 15333840 [TBL] [Abstract][Full Text] [Related]
4. Dopaminergic loss and inclusion body formation in alpha-synuclein mice: implications for neurodegenerative disorders. Masliah E; Rockenstein E; Veinbergs I; Mallory M; Hashimoto M; Takeda A; Sagara Y; Sisk A; Mucke L Science; 2000 Feb; 287(5456):1265-9. PubMed ID: 10678833 [TBL] [Abstract][Full Text] [Related]
5. Neuronal alpha-synucleinopathy with severe movement disorder in mice expressing A53T human alpha-synuclein. Giasson BI; Duda JE; Quinn SM; Zhang B; Trojanowski JQ; Lee VM Neuron; 2002 May; 34(4):521-33. PubMed ID: 12062037 [TBL] [Abstract][Full Text] [Related]
6. The discrepancy between presenilin subcellular localization and gamma-secretase processing of amyloid precursor protein. Cupers P; Bentahir M; Craessaerts K; Orlans I; Vanderstichele H; Saftig P; De Strooper B; Annaert W J Cell Biol; 2001 Aug; 154(4):731-40. PubMed ID: 11502763 [TBL] [Abstract][Full Text] [Related]
7. Neuronal and glial accumulation of alpha- and beta-synucleins in human lipidoses. Suzuki K; Iseki E; Togo T; Yamaguchi A; Katsuse O; Katsuyama K; Kanzaki S; Shiozaki K; Kawanishi C; Yamashita S; Tanaka Y; Yamanaka S; Hirayasu Y Acta Neuropathol; 2007 Nov; 114(5):481-9. PubMed ID: 17653558 [TBL] [Abstract][Full Text] [Related]
8. Deficiency of presenilin-1 inhibits the normal cleavage of amyloid precursor protein. De Strooper B; Saftig P; Craessaerts K; Vanderstichele H; Guhde G; Annaert W; Von Figura K; Van Leuven F Nature; 1998 Jan; 391(6665):387-90. PubMed ID: 9450754 [TBL] [Abstract][Full Text] [Related]
9. Alpha-synuclein: its biological function and role in neurodegenerative diseases. Kaplan B; Ratner V; Haas E J Mol Neurosci; 2003 Apr; 20(2):83-92. PubMed ID: 12794302 [TBL] [Abstract][Full Text] [Related]
10. Lewy bodies contain altered alpha-synuclein in brains of many familial Alzheimer's disease patients with mutations in presenilin and amyloid precursor protein genes. Lippa CF; Fujiwara H; Mann DM; Giasson B; Baba M; Schmidt ML; Nee LE; O'Connell B; Pollen DA; St George-Hyslop P; Ghetti B; Nochlin D; Bird TD; Cairns NJ; Lee VM; Iwatsubo T; Trojanowski JQ Am J Pathol; 1998 Nov; 153(5):1365-70. PubMed ID: 9811326 [TBL] [Abstract][Full Text] [Related]
11. Presenilin-1 deficiency leads to loss of Cajal-Retzius neurons and cortical dysplasia similar to human type 2 lissencephaly. Hartmann D; De Strooper B; Saftig P Curr Biol; 1999 Jul; 9(14):719-27. PubMed ID: 10421573 [TBL] [Abstract][Full Text] [Related]
12. More than just two peas in a pod: common amyloidogenic properties of tau and alpha-synuclein in neurodegenerative diseases. Lee VM; Giasson BI; Trojanowski JQ Trends Neurosci; 2004 Mar; 27(3):129-34. PubMed ID: 15036877 [TBL] [Abstract][Full Text] [Related]
13. Presenilin clinical mutations can affect gamma-secretase activity by different mechanisms. Bentahir M; Nyabi O; Verhamme J; Tolia A; Horré K; Wiltfang J; Esselmann H; De Strooper B J Neurochem; 2006 Feb; 96(3):732-42. PubMed ID: 16405513 [TBL] [Abstract][Full Text] [Related]
14. Clearance of alpha-synuclein oligomeric intermediates via the lysosomal degradation pathway. Lee HJ; Khoshaghideh F; Patel S; Lee SJ J Neurosci; 2004 Feb; 24(8):1888-96. PubMed ID: 14985429 [TBL] [Abstract][Full Text] [Related]
15. Lysosomal pathology associated with alpha-synuclein accumulation in transgenic models using an eGFP fusion protein. Rockenstein E; Schwach G; Ingolic E; Adame A; Crews L; Mante M; Pfragner R; Schreiner E; Windisch M; Masliah E J Neurosci Res; 2005 Apr; 80(2):247-59. PubMed ID: 15765523 [TBL] [Abstract][Full Text] [Related]